Can AI transform life sciences without better data? In this opinion piece, Imperagen CEO Guy Levy-Yurista argues that the biggest challenge is not the models themselves, but the quality and structure of the underlying data. He explains why a "closed-loop" approach is essential to unlocking real value in biotech, drug discovery and R&D.

Opinion article here: https://www.techfinitive.com/opinions/why-a-closed-loop-approach-is-the-only-way-ai-can-deliver-true-value-to-life-sciences-rd/

#AI #Healthcare #LifeSciences #researchanddevelopment